No Data
No Data
No Data
Xlife Sciences' Portfolio Company Veraxa Biotech Plans Merger With Nasdaq-listed Voyager Acquisition
Voyager Therapeutics Inc (VYGR) Q4 2024 Earnings Call Highlights: Strong Financial Position and ...
Promising Developments in Voyager Therapeutics' Alzheimer's Programs Highlight Potential of Dual Tau-Targeted Therapies
Top Executives Unload Thousands of Voyager Therapeutics Shares!
ROBINT Presenta Su Robótica De Última Generación En La Hannover Messe 2025, Reforzando Su Expansión Global
Voyager Presents Robust Preclinical Data From Tau Targeting Gene Therapy and Antibody Programs at AD/PD 2025